Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
5,1 USD | -3,23% |
|
-8,77% | -63,41% |
Vakgebied
Aantal werknemers: 255
Verkoop per activiteit
USD in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
Pharmaceutical
100,0
%
| 2 | 100,0 % | 12 | 100,0 % | +505,77% |
Verkoop per regio
USD in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
United States
100,0
%
| 2 | 100,0 % | 12 | 100,0 % | +505,77% |
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Sekar Kathiresan
FOU | Founder | 52 | 01-01-18 |
Allison Dorval
DFI | Director of Finance/CFO | 48 | 29-11-21 |
Andrew Ashe
PSD | President | 57 | 01-08-18 |
Jason Politi
CTO | Chief Tech/Sci/R&D Officer | 47 | 01-02-21 |
Richard Falzone
CTO | Chief Tech/Sci/R&D Officer | 50 | 01-04-21 |
Joan Nickerson
ADM | Chief Administrative Officer | 56 | 01-04-21 |
Troy Lister
CTO | Chief Tech/Sci/R&D Officer | - | 01-05-22 |
Andrew Bellinger
CTO | Chief Tech/Sci/R&D Officer | 46 | 01-10-19 |
Fred Fiedorek
CTO | Chief Tech/Sci/R&D Officer | 69 | 18-09-23 |
Andrew Sheely
CTO | Chief Tech/Sci/R&D Officer | - | - |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Burt Adelman
FOU | Founder | 71 | 01-01-18 |
Lonnel Coats
BRD | Director/Board Member | 58 | 08-08-22 |
Michael MacLean
BRD | Director/Board Member | 58 | 01-05-21 |
Sheila Mikhail
BRD | Director/Board Member | 57 | 01-04-21 |
Krishna Yeshwant
BRD | Director/Board Member | 45 | 01-08-18 |
Alexander Cumbo
BRD | Director/Board Member | 53 | 09-06-22 |
Sekar Kathiresan
FOU | Founder | 52 | 01-01-18 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 83 965 493 | 77 497 248 ( 92,30 %) | 0 | 92,30 % |
Bedrijfsgegevens
![Adres Verve Therapeutics, Inc.(VERV)](https://cdn.zonebourse.com/static/address/123776319.png)
Sector
![Consensus](/images/consensus_flch.gif)
Herzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
-63,41% | 428 mln. | |
+34,01% | 51,07 mld. | |
+34,55% | 38,61 mld. | |
-8,02% | 38,78 mld. | |
-8,98% | 27,32 mld. | |
+12,56% | 26,35 mld. | |
-19,62% | 19,46 mld. | |
+39,18% | 13,58 mld. | |
+31,47% | 12,46 mld. | |
-3,40% | 11,75 mld. |
- Beurs
- Aandelen
- Koers VERV
- Onderneming Verve Therapeutics, Inc.